# Lexington Partners

> Lexington Partners is a VC fund backing Health Care and Biotechnology. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 7
- Last investment: Jun 2026
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/lexington-partners/
- X (Twitter): https://twitter.com/LexingtonLP
- Website: http://www.lexingtonpartners.com
- Facebook: https://www.facebook.com/Lexington-Partners-136190359727963/

Lexington Partners is a VC fund in New York focused on Health Care and Biotechnology. Lexington Partners is one of the world's largest and most successful independent managers of secondary private equity and co-investment funds. Since 1990, Lexington Partners has organized 20 secondary funds and 10 co-investment pools with total capital of $55 billion. Its investors include more than 1,000 leading public and corporate pensionfunds, sovereign wealth funds, insurance companies, financial institutions, endowments, foundations, and family offices from more than 40 countries.

## Contacts

5 contacts available for Lexington Partners. Shizune tracks 9 team members at Lexington Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lexington-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Biotechnology | 2 | 29% |
| Medical | 1 | 14% |
| Analytics | 1 | 14% |
| Marketing | 1 | 14% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Secondary Market | 2 | 29% |
| Series C | 1 | 14% |
| Series D | 1 | 14% |
| Series F | 1 | 14% |
| Funding Round | 1 | 14% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bianca Borgella | Analyst | 0 | — |
| Brent R. Nicklas | Founder | 0 | — |
| Duncan A. Chapman | Partner | 0 | — |
| Jeffery Bloom | Partner | 2 | — |
| Jennifer W. Kheng | Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SageSure | SageSure Insurance Managers is a real estate firm that offers property insurance services. | $460M | Secondary Market | Jun 30, 2026 |  |
| AbsoluteCARE | AbsoluteCARE is conveniently located in both Atlanta and Baltimore. The company is a value-based integrated healthcare provider focusing on providing comprehensive and preventative care. It operates a patient-centered ambulatory intensive caring unit delivery model and becomes the primary care provider for the complex and highest utilizingpatients.It was founded in 2000 and is headquartered in Baltimore, Maryland. | $135M | Private Equity | Jul 22, 2025 |  |
| Sovrn | Sovrn offers products and services to tens of thousands of online publishers that help them grow, operate their business, understand their readership, and manage consumer data. Sovrn is dedicated to helping content creators do more of what they love, and less of what they don’t.The company is headquartered in Boulder, Colorado with offices in SanFrancisco, New York, and London. | $36M | Series C | Jul 26, 2022 |  |
| Sovrn | Sovrn offers products and services to tens of thousands of online publishers that help them grow, operate their business, understand their readership, and manage consumer data. Sovrn is dedicated to helping content creators do more of what they love, and less of what they don’t.The company is headquartered in Boulder, Colorado with offices in SanFrancisco, New York, and London. | $26.5M |  | Oct 19, 2018 |  |
| CardioKinetix | The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function. | $50M | Series F | Dec 08, 2014 |  |
| PowerVision | PowerVision is a private company focused on developing a novel accommodating intraocular lens, which is designed to restore True AccommodationTM. Their innovative FluidVisionTM accommodating intraocular lens (IOL) is poised to help individuals affected by presbyopia and/or cataracts regain the ability to dynamically adjust focus for clearvision at all distances.Fifty years ago, vision correction surgery was changed forever by the invention of the intraocular lens, which is used to treat a cataract – a clouding and hardening of the dime-sized, normally clear, crystalline lens inside your eye which can rob you of your vision in your 60’s, 70’s and 80’s.PowerVision set out to dramatically improve vision correction surgery again. They began the development of their FluidVision IOL, which mimics the way a healthy eye works and can restore clear vision at all distances, near, far, and everywhere in between. It uses a tiny amount of fluid inside the lens and natural eye muscles to change shape and adjust focus just the way your healthy eye does.For the more than 20 million people with cataracts in the U.S. and, ultimately, the more than 90 million with Presbyopia – the loss of ability to focus up close that affects people in their 40’s and 50’s – the FluidVision lens can potentially give them freedom from ever needing glasses, contacts or any vision correction procedure again. | $20M | Series D | Jan 29, 2014 |  |
| Osaic | Osaic provides the support, resources, and community designed for the future of wealth management. Osaic to ensure you have the solutions, support, and flexibility you need to make a difference in your clients’ lives – because we know that when they thrive, you do too. It was founded in 2016 and was headquartered in Phoenix, Arizona. |  | Secondary Market |  |  |

7 of 7 investments shown.

## Co-investors
- Archer Capital Group — VC Fund, 2 deals together
- [Foundry Group](https://shizune.co/investors/profile/foundry-group) — VC Fund, 2 deals together
- [Foundry Group](https://shizune.co/investors/profile/foundryvc) — VC Fund, 2 deals together
- [Kinderhook Industries](https://shizune.co/investors/profile/kinderhook-industries-2) — VC Fund, 2 deals together
- [Advanced Technology Ventures](https://shizune.co/investors/profile/advanced-technology-ventures) — VC Fund, 1 deal together
- [Barings](https://shizune.co/investors/profile/barings) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Salica](https://shizune.co/investors/profile/hambroperksltd) — VC Fund
- [Growth Engine](https://shizune.co/investors/profile/growth-engine-2cd7) — VC Fund
- [Marco Valta](https://shizune.co/investors/profile/marco-valta) — Angel Investor

## FAQ

### What does Lexington Partners invest in?

Lexington Partners invests primarily in Health Care, Biotechnology and Medical startups, most often at Secondary Market and Series C stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Lexington Partners?

Public channels for Lexington Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Lexington Partners?

The team at Lexington Partners includes Bianca Borgella (Analyst), Brent R. Nicklas (Founder) and Duncan A. Chapman (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co